Related Experiment Video
Updated: Jun 21, 2026

Highly Sensitive Measurement of Glomerular Permeability in Mice with Fluorescein Isothiocyanate-polysucrose 70
Published on: August 9, 2019
Microalbuminuria, is it so important?
1Department of Nephrology, University Hospital Center, Tirana, Albania. alketak@albmail.com
Abstract:
Microalbuminuria (defined as urinary albumin excretion of 30-300 mg/day, or 20-200 microg/min) is an earlier sign of vascular damage. It is a marker of general vascular dysfunction and nowadays is considered a predictor of worse outcomes for both kidney and heart patients. There is a significant correlation between blood pressure and microalbuminuria. Even high normal blood pressure is associated with significant higher frequency of microalbuminuria and this way may be a biomarker of increased cardiovascular risk. Microalbuminuria could be taken also, as an indicator of insulin resistance and of the increased renal and cardiovascular risk associated with metabolic syndrome. Renal involvement is a pivotal development in diabetes and microalbuminuria is generally the first clinical sign of renal dysfunction in diabetics. It is demonstrated that cardiovascular and renal risk is elevated even in the high normal range of microalbuminuria (below 30 mg/day). There is no doubt that therapies that prevent or delay the development of microalbuminuria and all measures that reduce it, may help to prevent or delay end organ damage.
Insights
Microalbuminuria, an early sign of vascular damage, is linked to higher blood pressure and increased cardiovascular risk. Early detection and intervention for microalbuminuria can help prevent kidney and heart complications.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Background:
- Microalbuminuria signifies early vascular damage and is a predictor of adverse outcomes in kidney and heart patients.
- A strong correlation exists between blood pressure and microalbuminuria, with even high-normal blood pressure increasing its frequency.
- Microalbuminuria serves as an indicator of insulin resistance and associated renal and cardiovascular risks in metabolic syndrome.
Purpose of the Study:
- To highlight microalbuminuria as an early indicator of vascular dysfunction.
- To emphasize the association between blood pressure, microalbuminuria, and cardiovascular risk.
- To underscore the role of microalbuminuria in diabetes and metabolic syndrome.
Main Methods:
- Review of existing literature on microalbuminuria.
- Analysis of the correlation between blood pressure and microalbuminuria.
- Evaluation of microalbuminuria as a biomarker for vascular and renal risk.
Main Results:
- Microalbuminuria is an early marker of vascular damage and a predictor of poor outcomes.
- Elevated blood pressure, including high-normal ranges, is significantly associated with higher microalbuminuria rates.
- Increased cardiovascular and renal risk is evident even in the high-normal range of microalbuminuria (below 30 mg/day).
Conclusions:
- Microalbuminuria is a crucial biomarker for general vascular dysfunction, insulin resistance, and metabolic syndrome.
- Therapeutic strategies aimed at preventing or reducing microalbuminuria can mitigate end-organ damage.
- Early identification and management of microalbuminuria are vital for patients with or at risk of kidney and heart disease.
Related Concept Videos
Diabetic Nephropathy
Nephrotic Syndrome II : Assessment and Medical Management
Urine Studies I: Urinalysis
Nephrotic Syndrome I : Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Serum Studies: Renal Function Tests

